Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients. | Cancer Sci | 2019 | 31361375 | PubTator, text mining | PubMed |
| Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications. | Int J Med Sci | 2019 | 31341411 | PubTator, text mining | PubMed |
| Clinicopathological features and prognosis of ciliated muconodular papillary tumor. | J Cardiothorac Surg | 2019 | 31340823 | PubTator, text mining | PubMed |
| The Role of the Extracellular Matrix in Cancer Stemness. | Front Cell Dev Biol | 2019 | 31334229 | PubTator, text mining | PubMed |
| Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. | FEBS J | 2019 | 31330086 | PubTator, text mining | PubMed |
| Transcriptome analysis identifies a robust gene expression program in the mouse intestinal epithelium on aging. | Sci Rep | 2019 | 31320724 | PubTator, text mining | PubMed |
| Fibroblasts in the Infarcted, Remodeling, and Failing Heart. | JACC Basic Transl Sci | 2019 | 31312768 | PubTator, text mining | PubMed |
| Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway. | Int J Mol Sci | 2019 | 31311100 | PubTator, text mining | PubMed |
| 2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy. | J Med Chem | 2019 | 31310125 | PubTator, text mining | PubMed |
| Chromosome-Level Alpaca Reference Genome VicPac3.1 Improves Genomic Insight Into the Biology of New World Camelids. | Front Genet | 2019 | 31293619 | PubTator, text mining | PubMed |
| Translational regulation of protrusion-localized RNAs involves silencing and clustering after transport. | Elife | 2019 | 31290739 | PubTator, text mining | PubMed |
| Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis. | Oncol Lett | 2019 | 31289489 | PubTator, text mining | PubMed |
| Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis. | Circ Res | 2019 | 31288631 | PubTator, text mining | PubMed |
| Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials. | Front Oncol | 2019 | 31281796 | PubTator, text mining | PubMed |
| Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments. | J Oncol | 2019 | 31281359 | PubTator, text mining | PubMed |
| Evaluation of Graphene Oxide Induced Cellular Toxicity and Transcriptome Analysis in Human Embryonic Kidney Cells. | Nanomaterials (Basel) | 2019 | 31269699 | PubTator, text mining | PubMed |
| Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance. | Cancers (Basel) | 2019 | 31266248 | PubTator, text mining | PubMed |
| Allogeneic adipose-derived stem cell transplantation on knee osteoarthritis rats and its effect on MMP-13 and DDR2. | Exp Ther Med | 2019 | 31258642 | PubTator, text mining | PubMed |
| Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets. | Cell Chem Biol | 2019 | 31257184 | PubTator, text mining | PubMed |
| High-Throughput Data Reveals Novel Circular RNAs via Competitive Endogenous RNA Networks Associated with Human Intracranial Aneurysms. | Med Sci Monit | 2019 | 31254341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=72